Skip to main content
Top
Published in: Annals of Surgical Oncology 9/2017

01-09-2017 | Pancreatic Tumors

CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma

Authors: Yasunari Fukuda, MD, Daisaku Yamada, MD, PhD, Hidetoshi Eguchi, MD, PhD, Tomoki Hata, MD, Yoshifumi Iwagami, MD, PhD, Takehiro Noda, MD, PhD, Tadafumi Asaoka, MD, PhD, Koichi Kawamoto, MD, Kunihito Gotoh, MD, PhD, Shogo Kobayashi, MD, PhD, Yutaka Takeda, MD, PhD, Masahiro Tanemura, MD, PhD, Masaki Mori, MD, PhD, Yuichiro Doki, MD, PhD

Published in: Annals of Surgical Oncology | Issue 9/2017

Login to get access

Abstract

Background

Fatty pancreas (FP) was recently recognized as a risk factor for pancreatic ductal adenocarcinoma (PDAC). It is unclear whether computed tomography (CT) can be used to make a FP diagnosis. This study investigated whether CT could provide a predictive value for PDAC by diagnosing FP.

Methods

The study included 183 consecutive patients who underwent distal pancreatectomy from February 2007 to January 2017, including 75 cases of PDAC and 108 cases of other pancreatic disease. Pancreatic CT density (pancreatic index; PI) at the initial diagnosis was calculated by dividing the CT number in the pancreas by the number in the spleen. To assess whether CT could be used to detect FP, 43 cases were evaluated pathologically for FP. We investigated the correlation between FP and PI, and determined the optimal PI cutoff value for detecting FP using receiver operating characteristics analysis. We then investigated whether the PI value could be used as a predictor for PDAC.

Results

Fourteen cases (32.6%) were pathologically diagnosed with FP. PI was significantly lower in the FP group versus the non-FP group (0.51 vs. 0.83; p = 0.0049). ROC analysis indicated that the PI had good diagnostic accuracy for FP diagnosis (cutoff value 0.70; sensitivity 0.79, specificity 0.79). Low PI (≤0.70) was identified in the multivariate analysis as an independent risk factor for PDAC (odds ratio 2.31; p = 0.023).

Conclusions

PI was strongly associated with pathological FP, which was independently associated with PDAC. PI shows promise as an imaging predictor for PDAC.
Appendix
Available only for authorised users
Literature
2.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors, 7th edn. Hoboken, NJ: John Wiley & Sons 2009. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors, 7th edn. Hoboken, NJ: John Wiley & Sons 2009.
4.
go back to reference Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817–25.CrossRefPubMed Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817–25.CrossRefPubMed
5.
go back to reference Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691-703.CrossRef Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691-703.CrossRef
6.
go back to reference Mizuguchi T, Torigoe T, Satomi F, et al. Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis? Surg Today. 2016;46:139-48.CrossRefPubMed Mizuguchi T, Torigoe T, Satomi F, et al. Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis? Surg Today. 2016;46:139-48.CrossRefPubMed
9.
10.
go back to reference Batabyal P, Vander Hoorn S, Christophi C, Nikfarjam M. Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Ann Surg Oncol. 2014;21:2453-62.CrossRefPubMed Batabyal P, Vander Hoorn S, Christophi C, Nikfarjam M. Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Ann Surg Oncol. 2014;21:2453-62.CrossRefPubMed
11.
go back to reference Hori M, Takahashi M, Hiraoka N, et al. Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma. Clin Transl Gastroenterol. 2014;5:e53.CrossRefPubMedPubMedCentral Hori M, Takahashi M, Hiraoka N, et al. Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma. Clin Transl Gastroenterol. 2014;5:e53.CrossRefPubMedPubMedCentral
12.
go back to reference Tomita Y, Azuma K, Nonaka Y, et al. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma. Pancreas. 2014;43:1032-41.CrossRefPubMed Tomita Y, Azuma K, Nonaka Y, et al. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma. Pancreas. 2014;43:1032-41.CrossRefPubMed
13.
go back to reference Rebours V, Gaujoux S, d’Assignies G, et al. Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions (PanIN). Clin Cancer Res. 2015;21:3522-8.CrossRefPubMed Rebours V, Gaujoux S, d’Assignies G, et al. Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions (PanIN). Clin Cancer Res. 2015;21:3522-8.CrossRefPubMed
14.
go back to reference Tariq H, Nayudu S, Akella S, Glandt M, Chilimuri S. Non-alcoholic fatty pancreatic disease: a review of literature. Gastroenterology Res. 2016;9:87-91.CrossRef Tariq H, Nayudu S, Akella S, Glandt M, Chilimuri S. Non-alcoholic fatty pancreatic disease: a review of literature. Gastroenterology Res. 2016;9:87-91.CrossRef
15.
go back to reference Wang H, Maitra A, Wang H. Obesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer. Clin Cancer Res. 2015;21:3369-71.CrossRefPubMed Wang H, Maitra A, Wang H. Obesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer. Clin Cancer Res. 2015;21:3369-71.CrossRefPubMed
16.
go back to reference Wang CY, Ou HY, Chen MF, Chang TC, Chang CJ. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. Am J Heart Assoc. 2014;3:e000297.CrossRef Wang CY, Ou HY, Chen MF, Chang TC, Chang CJ. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. Am J Heart Assoc. 2014;3:e000297.CrossRef
17.
go back to reference Lesmana CR, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross-sectional study. BMC Gastroenterol. 2015;15:174.CrossRefPubMedPubMedCentral Lesmana CR, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross-sectional study. BMC Gastroenterol. 2015;15:174.CrossRefPubMedPubMedCentral
18.
go back to reference Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med. 1979;67:811-6.CrossRefPubMed Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med. 1979;67:811-6.CrossRefPubMed
19.
go back to reference Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-74.CrossRefPubMed Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-74.CrossRefPubMed
20.
go back to reference Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108-13.CrossRefPubMed Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108-13.CrossRefPubMed
21.
go back to reference Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. Am J Roentgenol. 2007;188:1307-12.CrossRef Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. Am J Roentgenol. 2007;188:1307-12.CrossRef
22.
go back to reference Kim SY, Kim H, Cho JY, et al. Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology. 2014;271:104-12.CrossRefPubMed Kim SY, Kim H, Cho JY, et al. Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology. 2014;271:104-12.CrossRefPubMed
23.
go back to reference Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol. 2007;22:778-87.CrossRefPubMed Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol. 2007;22:778-87.CrossRefPubMed
24.
go back to reference Japan Diabetes Society. 2015. Treatment guide for diabetes 2014–2015 (in Japanese): BUNKODO. Japan Diabetes Society. 2015. Treatment guide for diabetes 2014–2015 (in Japanese): BUNKODO.
25.
go back to reference Fukuda Y, Yamada D, Eguchi H, et al. A novel preoperative predictor of pancreatic fistula using computed tomography after distal pancreatectomy with stapler closure. Surg Today. 2017 DOI:10.1007/s00595-017-1495-9 PubMed Fukuda Y, Yamada D, Eguchi H, et al. A novel preoperative predictor of pancreatic fistula using computed tomography after distal pancreatectomy with stapler closure. Surg Today. 2017 DOI:10.​1007/​s00595-017-1495-9 PubMed
26.
go back to reference Pecorelli N, Carrara G, De Cobelli F, et al. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg. 2016;103:434-42.CrossRefPubMed Pecorelli N, Carrara G, De Cobelli F, et al. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg. 2016;103:434-42.CrossRefPubMed
27.
go back to reference Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997-1006.CrossRefPubMed Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997-1006.CrossRefPubMed
28.
go back to reference Stolzenberg-Solomon RZ, Adams K, Leitzmann M, et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol. 2008;167:586-97.CrossRefPubMed Stolzenberg-Solomon RZ, Adams K, Leitzmann M, et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol. 2008;167:586-97.CrossRefPubMed
29.
go back to reference Ogilvie RF. The islands of Langerhans in 19 cases of obesity. J Pathol Bacterol. 1933;37:473-81.CrossRef Ogilvie RF. The islands of Langerhans in 19 cases of obesity. J Pathol Bacterol. 1933;37:473-81.CrossRef
30.
go back to reference Smits MM, van Geenen EJ. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol. 2011;8:169-77.CrossRefPubMed Smits MM, van Geenen EJ. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol. 2011;8:169-77.CrossRefPubMed
31.
go back to reference Mathur A, Pitt HA, Marine M, et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007;246:1058-64.CrossRefPubMed Mathur A, Pitt HA, Marine M, et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007;246:1058-64.CrossRefPubMed
32.
go back to reference Hori M, Kitahashi T, Imai T, et al. Enhancement of carcinogenesis and fatty infiltration in the pancreas in N-nitrosobis(2-oxopropyl)amine-treated hamsters by high-fat diet. Pancreas. 2011;40:1234-40.CrossRefPubMed Hori M, Kitahashi T, Imai T, et al. Enhancement of carcinogenesis and fatty infiltration in the pancreas in N-nitrosobis(2-oxopropyl)amine-treated hamsters by high-fat diet. Pancreas. 2011;40:1234-40.CrossRefPubMed
33.
go back to reference Philip B, Roland CL, Daniluk J, et al. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology. 2013;145:1449–58.CrossRefPubMed Philip B, Roland CL, Daniluk J, et al. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology. 2013;145:1449–58.CrossRefPubMed
34.
go back to reference Yardimci S, Kara YB, Tuney D, Attaallah W, Ugurlu MU, Dulundu E, Yegen ŞC. A simple method to evaluate whether pancreas texture can be used to predict pancreatic fistula risk after pancreatoduodenectomy. J Gastrointest Surg. 2015;19:1625-31.CrossRefPubMed Yardimci S, Kara YB, Tuney D, Attaallah W, Ugurlu MU, Dulundu E, Yegen ŞC. A simple method to evaluate whether pancreas texture can be used to predict pancreatic fistula risk after pancreatoduodenectomy. J Gastrointest Surg. 2015;19:1625-31.CrossRefPubMed
35.
go back to reference Sandini M, Bernasconi DP, Ippolito D, et al. Preoperative computed tomography to predict and stratify the risk of severe pancreatic fistula after pancreatoduodenectomy. Medicine (Baltimore). 2015;94:e1152.CrossRefPubMedPubMedCentral Sandini M, Bernasconi DP, Ippolito D, et al. Preoperative computed tomography to predict and stratify the risk of severe pancreatic fistula after pancreatoduodenectomy. Medicine (Baltimore). 2015;94:e1152.CrossRefPubMedPubMedCentral
Metadata
Title
CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma
Authors
Yasunari Fukuda, MD
Daisaku Yamada, MD, PhD
Hidetoshi Eguchi, MD, PhD
Tomoki Hata, MD
Yoshifumi Iwagami, MD, PhD
Takehiro Noda, MD, PhD
Tadafumi Asaoka, MD, PhD
Koichi Kawamoto, MD
Kunihito Gotoh, MD, PhD
Shogo Kobayashi, MD, PhD
Yutaka Takeda, MD, PhD
Masahiro Tanemura, MD, PhD
Masaki Mori, MD, PhD
Yuichiro Doki, MD, PhD
Publication date
01-09-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 9/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-5914-3

Other articles of this Issue 9/2017

Annals of Surgical Oncology 9/2017 Go to the issue